{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T16:33:27Z","timestamp":1789662807865,"version":"4.0.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"12","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CAR"],"published-print":{"date-parts":[[2018,9,28]]},"abstract":"<jats:sec>\n<jats:title>Introduction: <\/jats:title>\n<jats:p>Alzheimer's disease is known to be a chronic disease, with an estimated prevalence\nof about 10-30%, considering the population over 60 years of age. Most patients with this disorder\n(&gt; 95%) present the sporadic form, being characterized by a late onset (80-90 years of age), and it is the\nconsequence of the failure to clear the amyloid-\u03b2 (A\u03b2) peptide from the interstices of the brain. Significant\nnumbers of genetic risk factors for the sporadic disease have been researched. Some existing drugs\nfor Alzheimer's disease provide symptomatic benefit for up to 12 months, but there are no approved disease-\nmodifying therapies. In this line, a complementary strategy based on repositioning drugs which are\napproved for the treatment of other disorders could be interesting. It is noteworthy the fact that some\nclinical trials indicate that several classes of drugs own potent and beneficial effects on the Alzheimer's\ndisease treatment. In this present work, we present the details and evaluation of these alternative treatments.\nIt has highlighted several compounds with relevant evidence for this purpose, which deserves\nfurther investigation to clarify optimal treatment conditions in the clinical trials of patients with Alzheimer's\ndisease.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1567205015666180813150703","type":"journal-article","created":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T09:20:13Z","timestamp":1535361613000},"page":"1161-1178","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Insights into the Drug Repositioning Applied to the Alzheimer's Disease Treatment and Future Perspectives"],"prefix":"10.2174","volume":"15","author":[{"given":"Alexandre A.","family":"de Castro","sequence":"first","affiliation":[{"name":"Department of Chemistry, Federal University of Lavras, Lavras\/MG, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine F.F.","family":"da Cunha","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Lavras, Lavras\/MG, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander F.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Lavras, Lavras\/MG, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia V.","family":"Soares","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Lavras, Lavras\/MG, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel H.S.","family":"Leal","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Lavras, Lavras\/MG, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamil","family":"Kuca","sequence":"additional","affiliation":[{"name":"Center for Basic and Applied Research, University Hradec Kralove, Hradec Kralove, Czech Republic"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teodorico C.","family":"Ramalho","sequence":"additional","affiliation":[{"name":"Department of Chemistry, Federal University of Lavras, Lavras\/MG, 37200-000, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Current Alzheimer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/164645","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/164645\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/164645","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T16:01:49Z","timestamp":1609257709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/164645\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,28]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,9,28]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1567205015666180813150703","relation":{},"ISSN":["1567-2050"],"issn-type":[{"value":"1567-2050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9,28]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-04-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-06-10","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-07-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-09-28","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}